Ulf Petrusson, Director, Institute for Innovation and Social Change & Center for Intellectual Property, Chalmers University of Technology, University of Gothenburg, Sweden
Iain Thomas Head Life Sciences, Cambridge Enterprise, United Kingdom
There has recently been a rise in open innovation (OI) culture to increase the opportunities for generating cutting edge technologies and innovations to benefit society and the economy. Such examples include industry-funded PhDs, open data initiatives, competitions and multi-party consortia that share pre-competitive information and expertise.
This session presents an example of OI in the biomedical sector (where traditionally open innovation is underused) — the Stevenage Biocatalyst Centre (SBC) — the UK’s first biomedical open innovation campus. Using the example of the SBC, we will look at why OI is such an invaluable approach, how it can help to accelerate creation of new innovative solutions and how this is being achieved.
Moderator: Pascale Redig, Sr Category Manager, Janssen Pharmaceutica, Belgium | Member, Professional Development Committee, ASTP-Proton